Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Gold

Showing results (1-10 of 700) with videos related to

Pageof 70
Sort By:
Expert Review of Neurotherapeutics|December 3, 2013
New insights into multiple sclerosis and advances in multiple sclerosis spasticity managementRalf Gold
Expert Review of Neurotherapeutics|December 3, 2013
Multiple sclerosis spasticity epidemiology--key publicationsRalf Gold
CNS Drugs|December 7, 2010
Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approvedRalf Gold
International MS Journal|May 19, 2007
22nd ECTRIMS Congress, Madrid, Spain, 27,30 September 2006Ralf Gold
Expert Review of Neurotherapeutics|December 3, 2013
Multiple sclerosis spasticity management--key publicationsRalf Gold
Therapeutic Advances in Neurological Disorders|December 25, 2010
EditorialRalf Gold
Journal of Neuroimmunology|November 22, 2005
Overcoming failure to repair demyelination in EAE: an important step towards neuroprotection in multiple sclerosisRalf Gold
Journal of Neurology|April 9, 2008
Combination therapies in multiple sclerosisRalf Gold
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 12, 2024
Drug-induced lymphopenia: Are all fumarates the same?Ralf Gold, Jeremias Motte
Expert Opinion on Drug Metabolism & Toxicology|February 11, 2011
Laquinimod: a promising oral medication for the treatment of relapsing-remitting multiple sclerosisJan Thöne, Ralf Gold
Pageof 70

Showing results (1-10 of 700) with videos related to

Sort By:
Pageof 70
Expert Review of Neurotherapeutics|December 3, 2013
New insights into multiple sclerosis and advances in multiple sclerosis spasticity managementRalf Gold
Expert Review of Neurotherapeutics|December 3, 2013
Multiple sclerosis spasticity epidemiology--key publicationsRalf Gold
CNS Drugs|December 7, 2010
Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approvedRalf Gold
International MS Journal|May 19, 2007
22nd ECTRIMS Congress, Madrid, Spain, 27,30 September 2006Ralf Gold
Expert Review of Neurotherapeutics|December 3, 2013
Multiple sclerosis spasticity management--key publicationsRalf Gold
Therapeutic Advances in Neurological Disorders|December 25, 2010
EditorialRalf Gold
Journal of Neuroimmunology|November 22, 2005
Overcoming failure to repair demyelination in EAE: an important step towards neuroprotection in multiple sclerosisRalf Gold
Journal of Neurology|April 9, 2008
Combination therapies in multiple sclerosisRalf Gold
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 12, 2024
Drug-induced lymphopenia: Are all fumarates the same?Ralf Gold, Jeremias Motte
Expert Opinion on Drug Metabolism & Toxicology|February 11, 2011
Laquinimod: a promising oral medication for the treatment of relapsing-remitting multiple sclerosisJan Thöne, Ralf Gold
Pageof 70